Company News for Nov 12, 2024

Zacks

2024-11-12

ICL Group Ltd.’s (ICL) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.
Shares of $Aramark(ARMK-W)$ (ARMK) fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.
AbbVie Inc.’s (ABBV) shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials.
Shares of Sapiens International Corp. N.V. (SPNS) plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AbbVie Inc. (ABBV) : Free Stock Analysis Report

Aramark (ARMK) : Free Stock Analysis Report

ICL Group Ltd. (ICL) : Free Stock Analysis Report

Sapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2482700968"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2482700968\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2482700968?lang=zh_TW&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4LSyP71ZcbNSV.s5ZrKdnA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d12ae6d407957348a46f55b412dfc98","is_english":true,"pubTime":"2024-11-12 20:13","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2482700968","market":"us","top_or_hot":-1,"title":"Company News for Nov 12, 2024","media":"Zacks","content":"<html><body><ul>\n<li><span>ICL Group Ltd.’s (</span>ICL<span>) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.</span></li>\n<li><span>Shares of $Aramark(ARMK-W)$ (</span>ARMK<span>) fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.</span></li>\n<li><span>AbbVie Inc.’s (</span>ABBV<span>) shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials. </span></li>\n<li><span>Shares of <a href=\"https://laohu8.com/S/SPNS\">Sapiens International Corp</a>. N.V. (</span>SPNS<span>) plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million. </span></li>\n</ul>\n<p>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report</p>\n<p>AbbVie Inc. (ABBV) : Free Stock Analysis Report</p>\n<p><a href=\"https://laohu8.com/S/ARMK\">Aramark</a> (ARMK) : Free Stock Analysis Report</p>\n<p>ICL Group Ltd. (ICL) : Free Stock Analysis Report</p>\n<p>Sapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report</p>\n<p>To read this article on Zacks.com click here.</p>\n<p>Zacks Investment Research</p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Company News for Nov 12, 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCompany News for Nov 12, 2024\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Zacks</strong><span class=\"h-time small\">2024-11-12 20:13</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><ul>\n<li><span>ICL Group Ltd.’s (</span>ICL<span>) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.</span></li>\n<li><span>Shares of $Aramark(ARMK-W)$ (</span>ARMK<span>) fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.</span></li>\n<li><span>AbbVie Inc.’s (</span>ABBV<span>) shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials. </span></li>\n<li><span>Shares of <a href=\"https://laohu8.com/S/SPNS\">Sapiens International Corp</a>. N.V. (</span>SPNS<span>) plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million. </span></li>\n</ul>\n<p>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report</p>\n<p>AbbVie Inc. (ABBV) : Free Stock Analysis Report</p>\n<p><a href=\"https://laohu8.com/S/ARMK\">Aramark</a> (ARMK) : Free Stock Analysis Report</p>\n<p>ICL Group Ltd. (ICL) : Free Stock Analysis Report</p>\n<p>Sapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report</p>\n<p>To read this article on Zacks.com click here.</p>\n<p>Zacks Investment Research</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/company-news-nov-12-2024-121300792.html\">Zacks</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信貸持倉","start_time":0,"source_url":"https://finance.yahoo.com/news/company-news-nov-12-2024-121300792.html","article_id":"2482700968","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4LSyP71ZcbNSV.s5ZrKdnA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6d12ae6d407957348a46f55b412dfc98"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482700968","pubTimestamp":1731413580,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"ICL Group Ltd.’s  shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.Shares of Aramark  fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.AbbVie Inc.’s  shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials.Shares of Sapiens International Corp. N.V.  plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million.Want the latest recommendations from Zacks Investment Research?Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Sapiens International Corporation N.V.  : Free Stock Analysis Report. To read this article on Zacks.com click here.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4139":"生物科技","LU0882574055.USD":"富达全球健康医疗A ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","BK4566":"资本集团","LU0861579265.USD":"联博低波幅策略股票基金A","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","LU0122379950.USD":"贝莱德世界健康科学A2","SPNS":"Sapiens International Corp","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","BK4588":"碎股","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","ARMK":"Aramark","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","BK4581":"高盛持仓","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU0054578231.USD":"BGF SYSTEMATIC SUSTAINABLE GLOBAL SMALLCAP \"A2\" (USD) ACC","LU1989773731.SGD":"CPR Invest - Education A2 Acc SGD-H","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4093":"化肥与农用药剂","BK4209":"餐馆","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","ABBV":"艾伯维公司","ICL":"以色列化学","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4023":"应用软件","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H"},"translate_title":"2024年11月12日公司新闻","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":1,"ARMK":0.9,"ICL":1,"SPNS":1},"content_text":"ICL Group Ltd.’s (ICL) shares climbed 6% after the company reported third-quarter 2024 adjusted earnings per share of $0.11, surpassing the Zacks Consensus Estimate of $0.08.\nShares of $Aramark(ARMK-W)$ (ARMK) fell 1.1% after the company posted fourth-quarter fiscal 2024 revenues of $4,416.95 million, missing the Zacks Consensus Estimate of $4,439.46 million.\nAbbVie Inc.’s (ABBV) shares plummeted 12.6% after its experimental schizophrenia drug failed to show a statistically significant improvement in symptoms during two Phase 2 trials. \nShares of Sapiens International Corp. N.V. (SPNS) plunged 26.2% after posting third-quarter 2024 revenues of $137.03 million, lagging the Zacks Consensus Estimate of $140.34 million. \n\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nAbbVie Inc. (ABBV) : Free Stock Analysis Report\nAramark (ARMK) : Free Stock Analysis Report\nICL Group Ltd. (ICL) : Free Stock Analysis Report\nSapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}